There were three known signatures [signature 1 for aging, signature 5 for ERCC2 mutations, and signature 22 exposure to aristolochic acid (AA)] and two de novo mutational signatures, named signatures A and B, obtained by extracting mutation catalogs from Chinese ccRCC patients. Here, ERCC2 is linked to nonpapillary renal cell carcinoma.